174 related articles for article (PubMed ID: 37028837)
1. Gastrointestinal Tract Considerations: Part II: How Should a Rheumatologist Best Manage Common Lower Gastrointestinal Tract Complaints in Systemic Sclerosis?
Quinlivan A; McMahan ZH; Lee EB; Nikpour M
Rheum Dis Clin North Am; 2023 May; 49(2):319-336. PubMed ID: 37028837
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Tract Considerations Part I: How Should a Rheumatologist Best Manage Common Upper Gastrointestinal Tract Complaints in Systemic Sclerosis?
Quinlivan A; McMahan ZH; Lee EB; Nikpour M
Rheum Dis Clin North Am; 2023 May; 49(2):295-318. PubMed ID: 37028836
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis and the gut.
Butt S; Emmanuel A
Expert Rev Gastroenterol Hepatol; 2013 May; 7(4):331-9. PubMed ID: 23639091
[TBL] [Abstract][Full Text] [Related]
4. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis.
Kaniecki T; Abdi T; McMahan ZH
Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101666. PubMed ID: 33676855
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal complications of systemic sclerosis.
Tian XP; Zhang X
World J Gastroenterol; 2013 Nov; 19(41):7062-8. PubMed ID: 24222949
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and management of gastrointestinal manifestations in scleroderma.
Kirby DF; Chatterjee S
Curr Opin Rheumatol; 2014 Nov; 26(6):621-9. PubMed ID: 25207461
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment.
Volkmann ER; McMahan Z
Curr Opin Rheumatol; 2022 Nov; 34(6):328-336. PubMed ID: 35993874
[TBL] [Abstract][Full Text] [Related]
8. Measuring response in the gastrointestinal tract in systemic sclerosis.
Khanna D; Nagaraja V; Gladue H; Chey W; Pimentel M; Frech T
Curr Opin Rheumatol; 2013 Nov; 25(6):700-6. PubMed ID: 24047604
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis and Gut Microbiota Modulation in Systemic Sclerosis.
Lemos MPC; Zucoloto TG; Oliveira MC; de Oliveira GLV
J Clin Rheumatol; 2022 Mar; 28(2):e568-e573. PubMed ID: 34030162
[TBL] [Abstract][Full Text] [Related]
10. Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.
Kaniecki T; Hughes M; McMahan Z
Expert Rev Clin Immunol; 2024 Jun; 20(6):603-622. PubMed ID: 38406978
[TBL] [Abstract][Full Text] [Related]
11. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture-based modalities: novel alternative approaches in the treatment of gastrointestinal dysmotility in patients with systemic sclerosis.
Sallam HS; McNearney TA; Chen JD
Explore (NY); 2014; 10(1):44-52. PubMed ID: 24439095
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.
Gyger G; Baron M
Curr Rheumatol Rep; 2012 Feb; 14(1):22-9. PubMed ID: 22105546
[TBL] [Abstract][Full Text] [Related]
14. Systemic Sclerosis: Gastrointestinal Disease and Its Management.
Gyger G; Baron M
Rheum Dis Clin North Am; 2015 Aug; 41(3):459-73. PubMed ID: 26210129
[TBL] [Abstract][Full Text] [Related]
15. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre.
Thoua NM; Bunce C; Brough G; Forbes A; Emmanuel AV; Denton CP
Rheumatology (Oxford); 2010 Sep; 49(9):1770-5. PubMed ID: 20530510
[TBL] [Abstract][Full Text] [Related]
16. Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.
Hansi N; Thoua N; Carulli M; Chakravarty K; Lal S; Smyth A; Herrick A; Ogunbiyi O; Shaffer J; Mclaughlin J; Denton C; Ong V; Emmanuel AV; Murray CD
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-214-21. PubMed ID: 25372804
[TBL] [Abstract][Full Text] [Related]
17. [Gastrointestinal tract involvement in systemic sclerosis].
Renaud A; Jirka A; Durant C; Connault J; Espitia O; Takoudju C; Agard C
Rev Med Interne; 2023 Aug; 44(8):410-422. PubMed ID: 37270380
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal manifestations in Hungarian scleroderma patients.
Szamosi S; Szekanecz Z; Szucs G
Rheumatol Int; 2006 Oct; 26(12):1120-4. PubMed ID: 16770615
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management.
McMahan ZH; Kulkarni S; Chen J; Chen JZ; Xavier RJ; Pasricha PJ; Khanna D
Nat Rev Rheumatol; 2023 Mar; 19(3):166-181. PubMed ID: 36747090
[TBL] [Abstract][Full Text] [Related]
20. Current management of the gastrointestinal complications of systemic sclerosis.
Emmanuel A
Nat Rev Gastroenterol Hepatol; 2016 Aug; 13(8):461-72. PubMed ID: 27381075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
